Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV004998212 | SCV005620325 | benign | Autosomal recessive limb-girdle muscular dystrophy | 2025-01-08 | reviewed by expert panel | curation | The NM_003494.4: c.3065G>A variant in DYSF, which is also known as NM_001130987.2: c.3119G>A p.(Arg1040Gln), is a missense variant predicted to cause substitution of arginine by glutamine at amino acid 1022 (p.Arg1022Gln). The filtering allele frequency of the variant is 0.03338 for African/African American genome chromosomes in gnomAD v3.1.2 (the lower threshold of the 95% CI of 3745/152196), which is higher than the VCEP threshold of 0.003 (BA1). The SpliceAI score for this variant is 0.02, suggesting it does not impact splicing. However, the computational predictor REVEL gives a score of 0.39, which is above the LGMD VCEP threshold predicting a benign impact on DYSF function (≤0.1; BP4 not met). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/08/2025): BA1. |
Eurofins Ntd Llc |
RCV000080265 | SCV000112160 | benign | not specified | 2012-07-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080265 | SCV000309665 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000080265 | SCV000512917 | benign | not specified | 2016-01-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000526480 | SCV000649648 | benign | Qualitative or quantitative defects of dysferlin | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000526480 | SCV001300242 | likely benign | Qualitative or quantitative defects of dysferlin | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000080265 | SCV002050940 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001699117 | SCV002544048 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | DYSF: PM5, BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV001699117 | SCV005257062 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000080265 | SCV000151022 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Natera, |
RCV001276438 | SCV001462783 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000080265 | SCV001741993 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001699117 | SCV001925150 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001699117 | SCV001928133 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001699117 | SCV002035543 | likely benign | not provided | no assertion criteria provided | clinical testing |